Mankind Pharma

From Wikipedia, the free encyclopedia
Jump to navigation Jump to search

Mankind Pharma
Public
Industry Pharmaceutical
Founded 1995 (1995)
Founder R C Juneja
Headquarters Okhla, Delhi, India
Key people
Rajeev Juneja, Arjun Juneja, Sheetal Arora, P.K. Arora, Ajay Bansal
Products Pharmaceuticals, Generic drugs, OTC, FMCG, Diagnostics
Revenue US$ 600 million (2014-15)
Number of employees
10000+
Subsidiaries Discovery, Lifestar, Lifestar 2, Special, Vet, Future, Magnet
Website www.mankindpharma.com

Mankind Pharma is a pharmaceutical company in India based at New Delhi. The company has products in therapeutic areas ranging from unds, to gastrointestinal, cardiovascular, dermal, and erectile dysfunction medications.

History[edit]

Mankind Pharma, came into existence in 1986. In 1991, the company was formed into a legal corporation. It started working as a fully integrated pharmaceutical company in 1995 with the contributions of two brothers, R C Juneja and Rajeev Juneja. The seed capital for establishing the company was 50 Lakh.[1] The company was started with 20 employees and launched in two states in the 1st year of its operation.[2]

Products[edit]

Mankind’s products encompass pharmaceuticals and over the counter drugs. A few of its brands in India are Manforce condoms, Preganews, Unwanted 72, Gasofast, Healokind, Unwanted 21 days and Addiction deodorant.

Acquisition[edit]

The company acquired Magnet Labs Pvt. Ltd. to enter the antipsychotic segment in the year 2007.[3] Also it acquired Longifene-an appetite stimulant for children, in January 2010 which was earlier a brand of UCB Belgium.[4]

Business operation[edit]

The company has different marketing divisions & a company operating under its umbrella to expand its business operations in India namely Discovery, Future, Special, Vet, & Lifestar. Mankind has also entered the global arena by starting its operations in 22 overseas destinations across Asia, Africa, South-East Asia and Gulf countries mainly Sri Lanka, Myanmar, Cambodia,Vietnam, Philippines, Nepal, Nigeria, Kenya, Uganda, Zambia, Tanzania, Ethiopia & Rwanda.[5] The company has begun operations in the markets of Commonwealth Independent States, Uzbekistan and Tajikistan. Mankind Pharma also operates in USA with its subsidies company Lifestar Pharma LLC.[6]

Facilities[edit]

State-of-the-art manufacturing units at Paonta Sahib (Himachal Pradesh), built as per the USFDA/WHO guidelines. The company also has four major distribution offices in India located at Indore, Secundrabad Ghaziabad, & Meerut. The company has its own training & development center to train the sales workforce. Mankind has also established its Research & Development center in the year 2011.

Awards[edit]

The company has won accolades like Indian Express Pharma Pulse award for "Overall performance" in 2005 and "The Emerging Company of the Year" award at Pharma Excellence Award in 2007, "The India Business Icon (Pharma)" award by Network 18 for the year 2011, "Entrepreneur of the Year" by Ernst & Young in 2011,Honoured for the spirit of entrepreneurship with ‘Udyami Samman’ by Axis Group and Zee News (UP) in 2011, Acknowledgement of participation and support of Mankind in the 49th Annual National Conference of IAP by the Organisation Committee of Pedicon, 2012, Awarded for ‘Achieving Business Excellence’ by Citi Commercial Bank in 2012.[7]

References[edit]

  1. ^ Hussain, Shabana (8 May 2014). "Mankind Pharma: Formulating Strategy To Enter The Big League". Retrieved 27 June 2018. 
  2. ^ "A Giant Leap For Mankind". Business Outlook India. 24 December 2011. Archived from the original on 29 June 2012. Retrieved 5 February 2013. 
  3. ^ Acquisition of Magnet Labs[permanent dead link]
  4. ^ Mankind Pharma markets Longifene- 29 August 2011
  5. ^ A Giant Leap For Mankind -24 December 2011 Archived 29 June 2012 at the Wayback Machine.
  6. ^ "About Us – LifeStar". lifestarpharma.com. Retrieved 2017-11-14. 
  7. ^ [1][permanent dead link]

External links[edit]